BioAssay Works LLC (BAW) announces the retirement of Stephen Mefferd, BAW’s co-founder and President.  

During the past 20 years at BAW, Stephen has been instrumental in leading the company from a startup to a leading developer and manufacturer of lateral flow assays and reagents. Prior to founding BAW, Stephen worked at a multinational pharmaceutical company and a leading life science research tool company. Stephen also co-founded BioFX Laboratories, Inc., a company producing substrates and reagents for a variety of immunoassays (now part of Surmodics, Inc.)

“It has been a pleasure working with and among so many dedicated and talented individuals in the IVD/Biopharma industry for the past 53 years.  While my retirement may be chronologically overdue, making this exit is a challenge – it is difficult to leave when the work with the BAW team and customers is so rewarding”, said Stephen.  Stephen will be working with BAW on a reduced work schedule until the end of 2025 to insure a smooth transition. We wish him many happy and fulfilling days as a retiree in Skowhegan, Maine.